AG
RDUS

Artal Group’s Radius Health, Inc. RDUS Stock Holding History

Artal Group’s Portfolio RDUS Stock Details RDUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-300,000
Closed -$10.8M – 121
2018
Q1 		$10.8M Sell
300,000
-100,000
-25% -$3.61M 0.13% 47
2017
Q4 		$12.7M Buy
400,000
+150,000
+60% +$4.71M 0.19% 42
2017
Q3 		$9.64M Buy
250,000
+100,000
+67% +$3.93M 0.17% 43
2017
Q2 		$6.79M Sell
150,000
-100,000
-40% -$3.82M 0.12% 50
2017
Q1 		$9.66M Buy
250,000
+150,000
+150% +$6.29M 0.21% 43
2016
Q4 		$3.8M Buy
100,000
+50,000
+100% +$2.38M 0.08% 61
2016
Q3 		$2.71M Sell
50,000
-50,000
-50% -$2.54M 0.05% 80
2016
Q2 		$3.67M Buy
+100,000
New +$3.53M 0.08% 49

Other funds holding RDUS

BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

Artal Group's RDUS Position: Q2 2018 in Review

Artal Group sold out of Radius Health, Inc. (RDUS) in Q2 2018, closing a stake of 300,000 shares — an estimated $10.8M sold.

Artal Group first reported a position in RDUS in Q2 2016 and held it in 8 quarters. The position peaked at $12.7M in Q4 2017. 133 funds tracked by Wall St. Rank hold RDUS as of Q2 2018.

  • Artal Group reported no remaining Radius Health, Inc. position as of Q2 2018 after selling out during the quarter.
  • Artal Group sold 300,000 Radius Health, Inc. shares in Q2 2018, an estimated $10.8M.
  • Artal Group first reported a position in Radius Health, Inc. in Q2 2016 and held it in 8 quarters.
  • Artal Group's Radius Health, Inc. position peaked at $12.7M in Q4 2017.
  • 133 funds tracked by Wall St. Rank held Radius Health, Inc. as of Q2 2018.

Based on Artal Group's 13F filing for Q2 2018, filed 10 Aug 2018.